Medical Oncology

Prof. Dr. Yusuf Karakaş

Doctor and researcher Acıbadem Bodrum Hastanesi Muğla
Breast NeoplasmsLung NeoplasmsBrain NeoplasmsCarcinoma, Non-Small-Cell LungStomach NeoplasmsAdenocarcinoma
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 11 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 4 publications
  • Brain Neoplasms 3 publications
  • Carcinoma, Non-Small-Cell Lung 3 publications
  • Stomach Neoplasms 3 publications
  • Adenocarcinoma 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
  • Kolorektal Kanserler (Kolon ve Rektum Kanseri)
  • Meme Kanseri
  • Akciğer Kanseri
  • Kolon (Kalın Bağırsak) Kanseri

CV

Education and experience

From source

Experience

  • 2019Acıbadem Sağlık Grubuacibadem.com.tr
  • 2017 - 2019Hakkari Devlet Hastanesi / Cumhuriyet tarihinde Hakkariye atanan ve burada görev yapan ilk ve tek doktoracibadem.com.tr

Education

  • 2017Hacettepe Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
  • 2013Osmangazi Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
  • 2007Hacettepe Üniversitesi Tıp Fakültesi (İng), Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyacibadem.com.trFrom source
  • InstitutionAcıbadem Bodrum Hastanesiacibadem.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 11 publications · Model version —From source
  • Publications50 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 21:07https://www.acibadem.com.tr/doktor/yusuf-karakas/acibadem.com.tr

Scientific work

Publications on Breast Neoplasms

50 publications

  1. HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy

    Turkish Journal of Clinics and Laboratory, 2025

    DOI 10.18663/tjcl.1639022 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  2. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Clinical Breast Cancer, 2025

    DOI 10.1016/j.clbc.2025.03.003 PMID 40190010 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Ostracism in Adolescent Cancer Patients and Predictors (OSTRACA Study): A Pilot Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

    Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, 2025

    DOI 10.47572/muskutd.1503098 Source: OpenAlex

  4. Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-56046-w PMID 38461209 16 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study

    BMC Cancer, 2024

    DOI 10.1186/s12885-024-13357-5 PMID 39736618 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

    Journal of Geriatric Oncology, 2023

    DOI 10.1016/j.jgo.2023.101604 PMID 37683369 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

    Future Oncology, 2023

    DOI 10.2217/fon-2022-1287 PMID 37133230 22 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study

    Journal of Chemotherapy, 2022

    DOI 10.1080/1120009x.2022.2073159 PMID 35579894 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  9. Gastrointestinal Sistem Tümörleri-1

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1211 Open-access full textSource: OpenAlex

  10. Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience

    South Asian Journal of Cancer, 2022

    DOI 10.1055/s-0042-1755467 PMID 36756104 1 citation (Europe PMC) Open-access full textSource: OpenAlex

View all 50 publications